(firstQuint)Mix Vaccine for Metastatic Kidney Cancer.

 By enrolling patients with small metastases of kidney cancer adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of mix vaccine.

 The safety will be evaluated by statistics of adverse reactions.

 The efficacy will be evaluated according to local relief degree, progress free survival (PFS) and overall survival (OS).

.

 Mix Vaccine for Metastatic Kidney Cancer@highlight

The aim of this study is the safety and efficacy of mix vaccine to small metastases of kidney cancer.

